Final Expense Insurance with an Enlarged Prostate

Can You Get Final Expense Insurance with an Enlarged Prostate?

Yes. In almost every case, an enlarged prostate lands you in the level tier — day-one coverage at the company’s best price, with no waiting period and no surcharge.

Here is why. Final expense insurance uses simplified-issue underwriting. There are no medical exams, no blood draws, and no lab work of any kind. That means no PSA test result ever reaches the underwriter’s desk.

This is the single biggest difference between burial insurance and the term life policies most prostate articles are written about. Term life carriers pull labs, see your PSA number, and sometimes postpone the application over it. Final expense carriers never see that number at all.

There is a second reason the verdict is this clean. Most final expense applications do not ask about an enlarged prostate. It is not a knockout condition, it does not appear on the health questions, and it does not appear on the carrier’s decline list.

Choice Mutual, one of the largest final expense agencies in the country, publishes an eligibility list covering more than 60 high-risk health conditions. Enlarged prostate does not appear on it — the list runs from AIDS and aneurysm through wheelchair usage, and BPH is simply not treated as a risk factor worth listing.

So if you take Flomax, had a TURP procedure years ago, or get up three times a night, that alone does not change what you qualify for.

Where the verdict changes

An enlarged prostate does not hurt you. What can hurt you is something else in your file that happens to sit near the prostate.

If you are in one of the bottom three rows, the enlarged prostate is not what the underwriter is reacting to. The complication is. Everything above that line qualifies for the best funeral insurance rates available at your age.

How Carriers Underwrite an Enlarged Prostate

There are only two places a carrier can learn anything about your prostate: the health questions on the application, and the electronic prescription check they run in the background.

That is the whole picture. No exam, no doctor’s visit, no records request in most cases.

On the application, there is no question that says “do you have an enlarged prostate.” What exists instead are questions that a prostate problem can occasionally trip. These are the ones to know:

Answer no to all of those and your enlarged prostate is invisible to the underwriter.

The one that surprises people most is the pending-test question. If your urologist ordered a biopsy and you have not gotten the result back, most carriers will pause your application until you do. That is not a decline. It is a postpone, and it lifts the moment the result comes in benign.

The prescription check is the other half. Every simplified-issue carrier runs your name through a prescription database and a medical information exchange before they approve you. That check happens in seconds and you never see it.

Medications Underwriters Watch For with an Enlarged Prostate

Most prostate drugs are neutral. A few are not — not because the drug itself is a problem, but because it is also used to treat something serious, and the database does not tell the carrier which reason applies to you.

Here is how the underwriter reads them.

Group 1 — Neutral. These signal ordinary, managed BPH.

Alpha-blockers relax the muscle around the prostate and improve flow. They carry no negative signal on a burial insurance application.

• Tamsulosin (Flomax)
• Alfuzosin (Uroxatral)
• Silodosin (Rapaflo)

Two more alpha-blockers, terazosin (Hytrin) and doxazosin (Cardura), are also blood pressure medications. If you take one of these, the carrier may read it as high blood pressure rather than a prostate issue. Either way, controlled high blood pressure is also a level-tier condition, so nothing changes.

Group 2 — Neutral, but confirm the strength.

5-alpha reductase inhibitors shrink the prostate over time.

• Finasteride (Proscar) at 5 mg
• Dutasteride (Avodart)
• Dutasteride with tamsulosin (Jalyn)

Finasteride is also sold at 1 mg as Propecia for hair loss. The dosage tells the carrier which one you are on. Neither is a problem.

Group 3 — Neutral, with one thing to watch.

Tadalafil (Cialis) at 5 mg daily is approved for BPH symptoms. At 20 mg it is sold as Adcirca to treat pulmonary hypertension, which is a serious lung and heart condition that most carriers will not cover at the level tier. The dosage on the record is what separates the two, so make sure your agent knows why you take it.

Group 4 — Bladder medications. Usually neutral.

Anticholinergics like oxybutynin (Ditropan), tolterodine (Detrol), and solifenacin (Vesicare) treat overactive bladder symptoms that often travel with an enlarged prostate. Carriers rarely react to them on their own.

Group 5 — These are prostate cancer drugs, not BPH drugs.

If any of these appear in your prescription history, the carrier is no longer underwriting an enlarged prostate. It is underwriting cancer.

• Bicalutamide (Casodex)
• Leuprolide (Lupron, Eligard)
• Abiraterone (Zytiga)
• Enzalutamide (Xtandi)

Most final expense carriers treat drugs of this kind as active cancer treatment and respond with either a decline or a modified plan carrying a two-year waiting period. At least one carrier is known to be an exception and does not respond adversely to preventive prostate cancer medication. If you are on one of these, the answer is not on this page — it belongs to cancer underwriting, and the right carrier makes an enormous difference.

Group 6 — Complication signals.

These do not treat the prostate. They tell the underwriter the prostate caused a problem.

• Repeated courses of antibiotics for urinary tract infections
• Medications for chronic kidney disease
• Anything tied to a catheter or a recent hospitalization

Groups 1 through 4 cover the overwhelming majority of men reading this. If everything you take sits in those four groups, your enlarged prostate costs you nothing.

Best Companies and What You’ll Pay with an Enlarged Prostate

Because an enlarged prostate does not move you out of the level tier, the shopping question changes. You are not looking for a company that will “accept” your prostate. Almost all of them already do.

You are looking for the company with the lowest price at your age for the coverage you want.

That is a different problem, and it is worth understanding how carriers price the level tier. Most burial insurance companies with no waiting period break their product into one to three health classifications. The best health rating costs the least, the middle tier costs more, and the last one costs the most. Carriers call the best one “level” or “preferred,” the middle one “graded” or “standard,” and the most expensive one “modified” or “basic.”

Your enlarged prostate does not push you down a rung. There is no prostate surcharge, no rate adjustment, and no reduction in how much coverage you can buy.

What you’ll actually pay

Your price comes from four things: your exact age, your gender, whether you use tobacco, and how much coverage you buy. The prostate is not on that list.

Choice Mutual reports that final expense insurance runs roughly $50 to $100 a month for about $10,000 in coverage, though the true number swings widely by age. Industry rate data puts a 60-year-old at around $53 a month for $10,000, a 70-year-old at around $84, and an 80-year-old man at around $164 for the same coverage.

Those are level-tier numbers — the same ones a man with no prostate issue at all would pay.

Which companies to look at

Here is where most articles get vague, so let us be specific about what “best carrier for BPH” actually means in this market.

Since an enlarged prostate is not underwritten, no carrier is uniquely lenient toward it. The carriers worth naming are the ones that combine low level-tier pricing with sensible handling of the three things that do come up on a prostate file: a pending biopsy, a scheduled surgery, and prostate cancer medication in the prescription record.

Nearly all of the lowest-priced final expense carriers sell only through licensed agencies, and the plans companies sell directly to consumers are usually guaranteed acceptance policies — the most expensive kind, always carrying a two-year waiting period.

How to Get the Best Rate and Coverage with an Enlarged Prostate

Since the prostate itself does not cost you anything, the work here is about not accidentally creating a problem where none exists.

Answer the health questions honestly. There is no question about an enlarged prostate, so there is nothing to volunteer. But the questions that do exist — cancer, kidney disease, pending tests, scheduled surgery — must be answered truthfully. The carrier verifies your answers against the prescription database and the medical information exchange before it issues the policy, and again if you die in the first two years. Guessing wrong here is how a family loses a death benefit.

Know your dosages before you apply. Two of the common prostate medications are dose-dependent. Finasteride at 5 mg is a prostate drug; at 1 mg it is a hair loss drug. Tadalafil at 5 mg treats prostate symptoms; at 20 mg it treats a serious lung condition. If your agent knows which one you take, they can route you to a carrier that reads it correctly the first time.

Settle a pending test before you apply. If you are waiting on biopsy results, most carriers will postpone. Waiting two weeks for a benign result costs you nothing. Applying and getting postponed puts a record of that postponement into the system, which follows you to the next carrier.

Do the same with scheduled surgery. A TURP, laser procedure, UroLift, or Rezum on the calendar can trigger the “surgery advised or pending” question. Apply after you have recovered, not the week before.

Do not confuse this with term life advice. Nearly everything written about prostates and life insurance is about fully underwritten term policies, where the carrier draws blood, reads your PSA, and assigns a table rating. None of that applies to funeral insurance. There is no exam, no PSA, and no table rating. If an article is telling you to lower your PSA before applying, it is not talking about this product.

Buy through someone who represents many carriers. Level-tier pricing varies more between companies than most people expect, and you cannot see that spread from inside any one company’s website.

Do not fall for “guaranteed acceptance with no waiting period.” No company sells a guaranteed issue life insurance policy with no waiting period. If there are no health questions, there is a two-year to three-year waiting period. With an enlarged prostate, you almost certainly qualify for day-one coverage on a simplified-issue plan, which is both cheaper and better. There is no reason to accept a wait.

The short version: an enlarged prostate is one of the few common conditions in this market that genuinely costs you nothing. Protect that by applying to the right carrier, answering carefully, and timing the application around any pending test or procedure.